Kudrik, F. J., Rosenfeld, S. B., Reganti, S., Reddy, S. V., Choksi, R. J., Scott, J. A., Rui, A., Sharma, A., Sura, T., Aton, L., Gart, M., Lamb, A., Morere, L., Wang, B., Varughese, P., Gorantla, V. C. (2025). Factors impacting treatment with abemaciclib + endocrine therapy in high risk early-stage HR+/HER2- breast cancer patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e12521